Trial Profile
A study to unmask heart rate-independent effects β-blockers on pulse wave reflections by switching therapy from β-blockers to ivabradine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease; Hypertension
- Focus Therapeutic Use
- 22 Dec 2015 New trial record